Regulations and Regulatory Advocacy
The Centers for Medicare…
The Centers for Medicare & Medicaid Services will host a March 20 conference call to answer health care providers’ questions about preparing for the new Medicare beneficiary identifier.
The Centers for Medicare & Medicaid Services has clarified its inpatient rehabilitation facility medical review guidelines to confirm that auditors should not deny claims solely because a therapy time threshold, commonly referred to as the “3-hour rule,” was not met.
The Food and Drug Administration yesterday alerted health care professionals and patients not to use drug products produced by Cantrell Drug Co., including opioid products and other drugs intended for sterile injection, citing serious deficiencies in the company’s compounding operations.
A hospital’s penalty status in the Centers for Medicare & Medicaid Services’ Hospital-Acquired Conditions Reduction Program is heavily influenced by chance.
AHA comments to the Office of the National Coordinator for Health Information on its draft Trusted Exchange Framework and Common Agreement as well as ONC’s draft U.S. Core Data for Interoperability document.
The Drug Enforcement Administration will focus over the next 45 days on pharmacies and prescribers who are dispensing “unusual or disproportionate amounts” of prescription opioid drugs.
Press Release
New Report Shows Regulatory Burden Overwhelming Providers, Diverting Clinicians From Patient Care
FOR IMMEDIATE RELEASE
Contact: Marie Johnson - (202) 626-351
Colin Milligan - (202) 638-5491
Every day, hospitals, health systems and post-acute care providers confront the daunting task of complying with a growing number of federal regulations. They are constantly challenged to understand and implement new or revised regulations, while maintaining their core mission of providing high-…